CCND1 and breast cancer: Auraptene inhibited the proliferation of MDA-MB-231 and MCF-7 human breast cancer cells and significantly inhibited cyclin D1 dose-dependently and delayed tumor progression in rat mammary tumors (Krishnan et al., 2009).